About
Juliet Gray is a Professor of Paediatric Oncology, working in the Department of Paediatric Oncology at Southampton Children's Hospital and the Centre for Cancer Immunology at the University of Southampton. Her main clinical and research interest is in neuroblastoma and cancer immunotherapy. She leads a translational research group focused on the development of novel antibody therapies, and also leads a number of international clinical trials for children with neuroblastoma.
Research
Research groups
Research interests
- Fc modification of monoclonal antibodies to improve effector function
Research projects
Active projects
Researchers:
Researchers:
Sponsor: Childrens Cancer and Leukaemia Group
Researchers:
Sponsor: Cancer Research UK
Researchers:
Completed projects
Researchers:
Sponsor: Wessex Medical Research
Researchers:
Sponsor: Sparks Children's Medical Research Charity
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Wessex Cancer Trust
Sponsor: Childrens Cancer and Leukaemia Group
Researchers:
Researchers:
Researchers:
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Childrens Cancer and Leukaemia Group
Sponsor: Childrens Cancer and Leukaemia Group
Researchers:
Sponsor: Neuroblastoma UK
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Children with Cancer UK
Researchers:
Sponsor: Wessex Medical Research
Researchers:
Sponsor: Neuroblastoma UK
Researchers:
Sponsor: Childrens Cancer and Leukaemia Group
Researchers:
Publications
71 publications
Page 1 of 8
Holger N. Lode, Sascha Troschke-Meurer, Alberto Garaventa, Carla Manzitti, Roberto Luksch, Dominique Valteau-Couanet, Marion Gambart, John Anderson, Juliet Gray, Adela Canete, Lucas Moreno, Aleksandra Wieczorek, Cormac Owens, Shifra Ash, Isaac Yaniv, Genevieve Laureys, Hans Loibner, Ulrike Pötschger, Evgenia Glogova & Ruth Ladenstein,
2026, Journal of Clinical Oncology
Type: article
Thomas J. Jackson, Menna Shamma, Upeka Senanayake & Juliet Gray,
2026, Pediatric Blood and Cancer, 73(5)
Type: article
Jessica K.R. Boult, Diana M. Carvalho, Ketty Kessler & Juliet Gray,
2026, Neuro-Oncology Advances, 8(1)
Type: article
Sveva Castelli, Franziska Schulze, Theresa M. Thole-Kliesch & Juliet Gray,
2026, European Journal of Cancer , 236
Type: review
Lucas Moreno, Simon Gates, rebekah weston & Juliet Gray,
2026, Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Type: letterEditorial
Holger N. Lode, Przemysław Holko, Aleksandra Wieczorek, Katarzyna Sladowska, Nikolai Siebert, Dominique Valteau-Couanet, Alberto Garaventa, Adela Cañete, John Anderson, Isaac Yaniv, Shifra Ash, Lucas Moreno, Juliet Gray, Roberto Luksch, Genevieve Laureys, Cormac Owens, Carla Manzitti, Sascha Troschke-Meurer, Paweł Kawalec & Ruth L. Ladenstein,
2026, Frontiers in Oncology, 15
Type: article
Katherine Lehovsky, Christina Putnam, Nigel Hall, Juliet Gray & Zoë S. Walters,
2026, Pediatric Hematology and Oncology, 43(6), 344-354
Type: review
Aidan Kirk, Beki James, Richard G. Feltbower & Juliet Gray,
2025, British Journal of Haematology
DOI: 10.1111/bjh.70286
Type: article
Stephen G. Dubois, Lucas Moreno, Rochelle Bagatell & Juliet Gray,
2025, European Journal of Cancer, 231
Type: article
Juliet C. Gray, Rebekah Weston & Cormac Owens,
2025, Journal of Clinical Oncology
Type: article
External roles and responsibilities
Name:
Member of Scientific Advisory Board, Solving Kids Cancer (External organisation)
Role:
Member
Year:
2017 -
Name:
Member of Executive Commitee European Neuroblastom Reseach Network (SIOPEN) (External organisation)
Role:
Member
Year:
2015 - 2019
Name:
Member of NCRI Childhood Cancer Leukaemia Clinical Study Group (External organisation)
Role:
Member
Year:
2017 -
Name:
Member of CRUK Protocol Safety Review Board (External organisation)
Role:
Member
Year:
2016 -
Name:
Invited expert to NICE Single Technology Appraisal Committee (Anti-GD2 in neuroblastoma) (External organisation)
Role:
Member
Year:
2016 - 2018
Name:
Chair of NCRI CG Neuroblastoma subgroup (External organisation)
Role:
Chair
Year:
2018 -
Name:
Member of national paediatric Experimental Cancer Medicine Centre Steering Group (External organisation)
Role:
Member
Year:
2017 -
Name:
SIOPEN European Neuroblastoma Research Network, Chair of Clinical Trials Committee (External organisation)
Role:
Chair
Year:
2020 -
Name:
Irish Cancer Society (External organisation)
Role:
Member
Year:
2020
Name:
Neuroblastoma Australia - member of Scientific Advisory Board (External organisation)
Role:
Chair
Year:
2019 -
Name:
External examiner MSc in Cancer Immunology and Biotechnology, University of Nottingham
Role:
Examiner
Year:
2018
Name:
Member of National Neuroblastoma Advisory Panel
Role:
Other
Year:
2017
Name:
Thames Valley and Wessex Children's Cancer Operational Delivery Network, Clinical lead
Role:
Other
Year:
2021
Biography
- Early phase immunotherapy trials for neuroblastoma
Prizes
- ‘Outstanding Principal Investigator’ CRN Wessex Awards 2018: (2018)
- Solving Kids Cancer Research Hero (2022)